Side-by-side comparison of AI visibility scores, market position, and capabilities
US YC W23 digital CBT-I sleep therapy at $60/month with 50% better results than sleeping pills; $6.5M total ($6M Initialized/YC/Goodwater seed Feb 2024) treating chronic insomnia psychologically competing with Sleepio.
Stellar Sleep is a United States-based digital sleep therapy platform — backed by Y Combinator (W23) with $6.5 million in total funding including a $6 million seed in February 2024 led by Initialized Capital with Y Combinator, Lombardstreet Ventures, Switch Ventures, Moonfire Ventures, Scrum Ventures, 8vdx, and Goodwater Capital — providing chronic insomnia sufferers with a $60/month mobile app that delivers CBT-I (cognitive behavioral therapy for insomnia), acceptance and commitment therapy, and motivational interviewing through a structured program clinically validated to be 50% more effective than sleeping pills for long-term insomnia resolution. Founded in 2023, Stellar Sleep treats the root psychological and behavioral causes of insomnia rather than masking symptoms with pharmaceutical or supplement approaches.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.